Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial

Moss, Sue M., Cuckle, Howard, Evans, Andy, Johns, Louise, Waller, Michael, Bobrow, Lynda and Trial Management Group (2006) Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. The Lancet, 368 9552: 2053-2060. doi:10.1016/S0140-6736(06)69834-6


Author Moss, Sue M.
Cuckle, Howard
Evans, Andy
Johns, Louise
Waller, Michael
Bobrow, Lynda
Trial Management Group
Title Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial
Journal name The Lancet   Check publisher's open access policy
ISSN 0140-6736
1474-547X
Publication date 2006-12-01
Year available 2011
Sub-type Article (original research)
DOI 10.1016/S0140-6736(06)69834-6
Open Access Status DOI
Volume 368
Issue 9552
Start page 2053
End page 2060
Total pages 8
Place of publication London
Publisher Lancet Publishing Group
Language eng
Subject 010402 Biostatistics
111706 Epidemiology
Formatted abstract
Background
The efficacy of screening by mammography has been shown in randomised controlled trials in women aged 50 years and older, but is less clear in younger women. A meta-analysis of all previous trials showed a 15% mortality reduction in invited women aged 40–49 years at study entry, but this finding could be due in part to screening of women after age 50 years. The Age trial was designed to study the effect on mortality of inviting women for annual mammography from age 40 years.

Methods

160 921 women aged 39–41 years were randomly assigned in the ratio 1:2 to an intervention group of annual mammography to age 48 years or to a control group of usual medical care. The trial was undertaken in 23 NHS breast-screening units in England, Wales, and Scotland. The primary analysis was based on the intention-to-treat principle and compared mortality rates in the two groups at 10 years' follow-up. This study is registered as an International Standard Randomised Controlled Trial, number ISRCTN24647151.

Findings
At a mean follow-up of 10·7 years there was a reduction in breast-cancer mortality in the intervention group, in relative and absolute terms, which did not reach statistical significance (relative risk 0·83 [95% CI 0·66–1·04], p=0·11; absolute risk reduction 0·40 per 1000 women invited to screening [95% CI −0·07 to 0·87]). Mortality reduction adjusted for non-compliance in women actually screened was estimated as 24% (RR 0·76, 95% CI 0·51–1·01).

Interpretation
Although the reduction in breast-cancer mortality observed in this trial is not significant, it is consistent with results of other trials of mammography alone in this age-group. Future decisions on screening policy should be informed by further follow-up from this trial and should take account of possible costs and harms as well as benefits.
Keyword Oncology
Oncology
ONCOLOGY
Q-Index Code C1
Grant ID CA-75362
Institutional Status Non-UQ

Document type: Journal Article
Sub-type: Article (original research)
Collections: Excellence in Research Australia (ERA) - Collection
Centre for Military and Veterans' Health Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 292 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 339 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Sat, 04 Apr 2009, 00:44:15 EST by Ms Sarada Rao on behalf of Centre for Australian Military & Veterans' Health